Literature DB >> 20089662

HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.

Jean-Philippe Belzile1, Jonathan Richard, Nicole Rougeau, Yong Xiao, Eric A Cohen.   

Abstract

HIV-1 viral protein R (Vpr) induces cell cycle arrest at the G(2)/M phase by a mechanism involving the activation of the DNA damage sensor ATR. We and others recently showed that Vpr performs this function by subverting the activity of the DDB1-CUL4A (VPRBP) E3 ubiquitin ligase. Vpr could thus act as a connector between the E3 ligase and an unknown cellular factor whose ubiquitination would induce G(2) arrest. While attractive, this model is based solely on the indirect observation that some mutants of Vpr retain their interaction with the E3 ligase but fail to induce G(2) arrest. Using a tandem affinity purification approach, we observed that Vpr interacts with ubiquitinated cellular proteins and that this association requires the recruitment of an active E3 ligase given that the depletion of VPRBP by RNA interference or the overexpression of a dominant negative mutant of CUL4A decreased this association. Importantly, G(2)-arrest-defective mutants of Vpr in the C-terminal putative substrate-interacting domain displayed a decreased association with ubiquitinated proteins. We also found that the inhibition of proteasomal activity increased this association and that the ubiquitin chains were at least in part constituted of classical K48 linkages. Interestingly, the inhibition of K48 polyubiquitination specifically impaired the Vpr-induced phosphorylation of H2AX, an early target of ATR, but did not affect UV-induced H2AX phosphorylation. Overall, our results provide direct evidence that the association of Vpr with the DDB1-CUL4A (VPRBP) E3 ubiquitin ligase induces the K48-linked polyubiquitination of as-yet-unknown cellular proteins, resulting in their proteasomal degradation and ultimately leading to the activation of ATR and G(2) arrest.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089662      PMCID: PMC2838092          DOI: 10.1128/JVI.02590-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage.

Authors:  Hengbin Wang; Ling Zhai; Jun Xu; Heui-Yun Joo; Sarah Jackson; Hediye Erdjument-Bromage; Paul Tempst; Yue Xiong; Yi Zhang
Journal:  Mol Cell       Date:  2006-05-05       Impact factor: 17.970

2.  Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.

Authors:  Stephane Angers; Ti Li; Xianhua Yi; Michael J MacCoss; Randall T Moon; Ning Zheng
Journal:  Nature       Date:  2006-10-05       Impact factor: 49.962

3.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

4.  DDB1 maintains genome integrity through regulation of Cdt1.

Authors:  Courtney A Lovejoy; Kimberli Lock; Ashwini Yenamandra; David Cortez
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

5.  Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.

Authors:  Erik S Zimmerman; Michael P Sherman; Jana L Blackett; Jason A Neidleman; Christophe Kreis; Pamela Mundt; Samuel A Williams; Maria Warmerdam; James Kahn; Frederick M Hecht; Robert M Grant; Carlos M C de Noronha; Andrew S Weyrich; Warner C Greene; Vicente Planelles
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 6.  Viral modulators of cullin RING ubiquitin ligases: culling the host defense.

Authors:  Michele Barry; Klaus Früh
Journal:  Sci STKE       Date:  2006-05-16

7.  L2DTL/CDT2 interacts with the CUL4/DDB1 complex and PCNA and regulates CDT1 proteolysis in response to DNA damage.

Authors:  Leigh Ann Higa; Damon Banks; Min Wu; Ryuji Kobayashi; Hong Sun; Hui Zhang
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

8.  Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases.

Authors:  Bärbel Schröfelbauer; Qin Yu; Samantha G Zeitlin; Nathaniel R Landau
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection.

Authors:  Anna Bergamaschi; Diana Ayinde; Annie David; Erwann Le Rouzic; Marina Morel; Gilles Collin; Diane Descamps; Florence Damond; Françoise Brun-Vezinet; Sebastien Nisole; Florence Margottin-Goguet; Gianfranco Pancino; Catherine Transy
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

10.  The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites.

Authors:  Maria G Kapetanaki; Jennifer Guerrero-Santoro; Dawn C Bisi; Ching L Hsieh; Vesna Rapić-Otrin; Arthur S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

View more
  34 in total

1.  Modulation of NKG2D-mediated cytotoxic functions of natural killer cells by viral protein R from HIV-1 primary isolates.

Authors:  Tram N Q Pham; Jonathan Richard; Francine C A Gerard; Christopher Power; Éric A Cohen
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.

Authors:  Bizhan Romani; Nima Shaykh Baygloo; Mojtaba Hamidi-Fard; Mohammad Reza Aghasadeghi; Elham Allahbakhshi
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

3.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.

Authors:  Jinwoo Ahn; Thomas Vu; Zach Novince; Jennifer Guerrero-Santoro; Vesna Rapic-Otrin; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

5.  Viral protein R upregulates expression of ULBP2 on uninfected bystander cells during HIV-1 infection of primary CD4+ T lymphocytes.

Authors:  Jonathan Richard; Tram N Q Pham; Yukihito Ishizaka; Eric A Cohen
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 6.  The functions of the HIV1 protein Vpr and its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase.

Authors:  Laurieann Casey; Xiaoyun Wen; Carlos M C de Noronha
Journal:  Cytokine       Date:  2010-03-27       Impact factor: 3.861

7.  Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.

Authors:  Eugene Boon Beng Ong; Nobumoto Watanabe; Akiko Saito; Yushi Futamura; Khaled Hussein Abd El Galil; Atsushi Koito; Nazalan Najimudin; Hiroyuki Osada
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

Review 8.  Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase.

Authors:  Bizhan Romani; Eric A Cohen
Journal:  Curr Opin Virol       Date:  2012-10-10       Impact factor: 7.090

9.  Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Authors:  Claire Maudet; Matthieu Bertrand; Erwann Le Rouzic; Hichem Lahouassa; Diana Ayinde; Sébastien Nisole; Caroline Goujon; Andrea Cimarelli; Florence Margottin-Goguet; Catherine Transy
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

10.  HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.

Authors:  Ge Li; Robert T Elder; Larisa Dubrovsky; Dong Liang; Tatiana Pushkarsky; Karen Chiu; Tao Fan; Josephine Sire; Michael Bukrinsky; Richard Y Zhao
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.